SCHEMBL16638244

SCHEMBL16638244

COCCOCCNC(=O)Nc1cccc(C2CN(C)Cc3c(Cl)cc(Cl)cc32)c1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC9A3 P48764 15/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4033153 0.95 SLC9A3 (0.68) SLC9A3
SCHEMBL13449852 0.93 SLC9A3 (0.73) SLC9A3
SCHEMBL16638578 0.93 SLC9A3 (0.70) SLC9A3
SCHEMBL2572270 0.93 SLC9A3 (0.72) SLC9A3
SCHEMBL20362306 0.93 SLC9A3 (0.72) SLC9A3
SCHEMBL16473637 0.92 SLC9A3 (0.70) SLC9A3
SCHEMBL13276151 0.91 SLC9A3 (0.73) SLC9A3
SCHEMBL13466610 0.89 SLC9A3 (0.70) SLC9A3
SCHEMBL20362295 0.89 SLC9A3 (0.68) SLC9A3
SCHEMBL13467433 0.89 SLC9A3 (0.68) SLC9A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006281-B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders ARDELYX, INC. (US) 2015-04-14 US disclosed
US-9006281-B2 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders ARDELYX, INC. (US) 2015-04-14 US disclosed